AlexisScherlMDPhD(She/Her)
Pathology • South San Francisco, CAGastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology
Scientist - Pathology
Dr. Scherl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 DNA Way
Mail stop 72B
South San Francisco, CA 94080Phone+1 650-225-5576
Summary
- Dr. Alexis Scherl is a pathologist in South San Francisco, CA. She received her medical degree from Albert Einstein College of Medicine and has been in practice 8 years. She specializes in gastrointestinal & hepatobiliary pathology and anatomic pathology and is experienced in biomedical research.
Education & Training
Yale-New Haven HospitalSelective Pathology, 2012 - 2013
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2009 - 2012
Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2013 - 2025
CT State Medical License 2012 - 2014- American Board of Pathology Pathology - Anatomic
Clinical Trials
- A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors Start of enrollment: 2014 Nov 04
- A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors Start of enrollment: 2014 Aug 12
Publications & Presentations
PubMed
- 28 citationsDual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel diseaseBingbing Dai, Jason A. Hackney, Ryan Ichikawa, Allen Nguyen, Justin Elstrott
Cell Reports. Medicine. 2021-08-17 - 5 citationsAn agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseases.Markus M Xie, Bingbing Dai, Jason A Hackney, Tianhe Sun, Juan Zhang
Cell Reports. Medicine. 2023-08-15 - 73 citationsIntratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.Romain Banchereau, Avantika S. Chitre, Alexis Scherl, Thomas D. Wu, Namrata Patil
Journal for Immunotherapy of Cancer. 2021-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
